A comprehensive insight into the anti-inflammatory properties of dapsone
- 20 September 2022
- journal article
- review article
- Published by Springer Nature in Naunyn-Schmiedeberg's Archives of Pharmacology
- Vol. 395 (12) , 1509-1523
Abstract
The 4,4′-diaminodiphenyl sulfone (DDS), also known as dapsone, is traditionally used as a potent anti-bacterial agent in clinical management of leprosy. For decades, dapsone has been among the first-line medications used in multidrug treatment of leprosy recommended by the World Health Organization (WHO). Shortly after dapsone’s discovery as an antibiotic in 1937, the dual function of dapsone (anti-microbial and anti-inflammatory) was elucidated. Dapsone exerts its anti-bacterial effects by inhibiting dihydrofolic acid synthesis, leading to inhibition of bacterial growth, while its anti-inflammatory properties are triggered by inhibiting reactive oxygen species (ROS) production, reducing the effect of eosinophil peroxidase on mast cells and downregulating neutrophil-mediated inflammatory responses. Among the leading mechanisms associated with its anti-microbial/anti-protozoal effects, dapsone clearly has multiple antioxidant, anti-inflammatory, and anti-apoptotic functions. In this regard, it has been described in treating a wide variety of inflammatory and infectious skin conditions. Previous reports have explored different molecular targets for dapsone and provided insight into the anti-inflammatory mechanism of dapsone. This article reviews several basic, experimental, and clinical approaches on anti-inflammatory effect of dapsone. Graphical abstractKeywords
This publication has 134 references indexed in Scilit:
- Suppression of ROS generation by 4,4'-diaminodiphenylsulfone in non-phagocytic human diploid fibroblastsExperimental & Molecular Medicine, 2010
- Efficacy of Dapsone in the Treatment of Pemphigus and PemphigoidAmerican Journal of Clinical Dermatology, 2009
- Epidermolysis Bullosa Acquisita Responsive to Dapsone TherapyJournal of Cutaneous Medicine and Surgery, 2001
- Dapsone hypersensitivity syndromeJournal of the American Academy of Dermatology, 1996
- Treatment of bullous pemphigoid with dapsone: Retrospective study of thirty-six casesJournal of the American Academy of Dermatology, 1996
- The effect of dapsone in steroid-dependent asthmaJournal of Allergy and Clinical Immunology, 1991
- Clinical Pharmacokinetics of DapsoneClinical Pharmacokinetics, 1986
- Comparative effects of drugs on four paw oedema models in the ratInflammation Research, 1979
- The anti-inflammatory profile of dapsone in animal models of inflammationInflammation Research, 1978
- A comparison of the anti-inflammatory effects of copper aspirinate and other copper salts in the rat and guinea pigInflammation Research, 1978